Xia Meng
Corporate Officer/Principal bei CELLULAR BIOMEDICINE GROUP, INC.
Profil
Xia Meng is currently the Head-Early Diagnosis & Intervention at AbelZeta Pharma, Inc. Prior to this, Dr. Meng held positions as the Head-Institute Merieux Laboratory at Fudan University Shanghai Cancer Center, and as the General Manager at both Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
and Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Dr. Meng completed an undergraduate degree at Wuhan University and a doctorate degree at Université Pierre et Marie Curie.
Aktive Positionen von Xia Meng
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Corporate Officer/Principal | 06.02.2018 |
Ehemalige bekannte Positionen von Xia Meng
| Unternehmen | Position | Ende |
|---|---|---|
| Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Corporate Officer/Principal | - |
Fudan University Shanghai Cancer Center
 Fudan University Shanghai Cancer Center Pharmaceuticals: OtherHealth Technology Fudan University Shanghai Cancer Center is a cancer center that operates in Shanghai, CN. The center was founded in 1931. | Corporate Officer/Principal | - |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Corporate Officer/Principal | - |
Ausbildung von Xia Meng
| Wuhan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
Fudan University Shanghai Cancer Center
Fudan University Shanghai Cancer Center Pharmaceuticals: OtherHealth Technology Fudan University Shanghai Cancer Center is a cancer center that operates in Shanghai, CN. The center was founded in 1931. | Health Technology |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
AbelZeta Pharma, Inc.
 AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
| Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. |
